Review



cell line molt16  (DSMZ)


Bioz Verified Symbol DSMZ is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    DSMZ cell line molt16
    Cell Line Molt16, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 51 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+line+molt16/MOLT-16/bio_rxiv__2024__09__05__611385-34-1-4
    Average 94 stars, based on 51 article reviews
    cell line molt16 - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Cell Culture:

    Article Title: The CNS Microenvironment Promotes Leukemia Cell Survival by Disrupting Tumor Suppression and Cell Cycle Regulation in Pediatric T-cell Acute Lymphoblastic Leukemia
    Article Snippet: T-ALL cell lines CCL-119, Jurkat and SUP-T1 (ATCC) were cultured in suspension in RPMI with 10% FBS (Sigma-Aldrich). .. T-ALL cell line MOLT16 (Leibniz Institute DSMZ) was cultured in suspension IMDM (Gibco) with 10% FBS. .. Glioblastoma cell line U87-MG (ATCC) was maintained as adherent culture in ATCC modified Eagle’s Minimum Essential Medium (ATCC) passaged by detachment using 0.25% trypsin-EDTA (Gibco).

    Article Title: The CNS microenvironment promotes leukemia cell survival by disrupting tumor suppression and cell cycle regulation in pediatric T-cell acute lymphoblastic leukemia.
    Article Snippet: T-ALL cell lines CCL-119 and SUP-T1 (ATCC) were cultured in suspension in RPMI with 10% FBS (Sigma-Aldrich). .. T-ALL cell line MOLT16 (Leibniz Institute DSMZ) was cultured in suspension in IMDM (Gibco) with 10% FBS. .. Immortalized Human Meningeal Cells (IMHMCs) (Innoprot) were cultured in complete Meningeal Cell Medium (MenCM) (Innoprot) and passaged by detachment using Primary Cells Detach Kit (Innoprot).

    Article Title: A Distinct Alternative mRNA Splicing Profile Identifies the Oncogenic CD44 Transcript Variant 3 in KMT2A-Rearranged Pediatric T-cell Acute Lymphoblastic Leukemia Cells
    Article Snippet: T-ALL cell lines Jurkat and CCL-119 (ATCC) were cultured in suspension in RPMI with 10% FBS (Sigma-Aldrich). .. T-ALL cell line MOLT16 (Leibniz Institute DSMZ) was cultured in suspension in IMDM (Gibco) with 10% FBS. .. KMT2A-r cell line KARPAS-45 was cultured in suspension using RPMI supplemented with 2mM glutamine and 20% FBS (Sigma-Aldrich).

    Suspension:

    Article Title: The CNS Microenvironment Promotes Leukemia Cell Survival by Disrupting Tumor Suppression and Cell Cycle Regulation in Pediatric T-cell Acute Lymphoblastic Leukemia
    Article Snippet: T-ALL cell lines CCL-119, Jurkat and SUP-T1 (ATCC) were cultured in suspension in RPMI with 10% FBS (Sigma-Aldrich). .. T-ALL cell line MOLT16 (Leibniz Institute DSMZ) was cultured in suspension IMDM (Gibco) with 10% FBS. .. Glioblastoma cell line U87-MG (ATCC) was maintained as adherent culture in ATCC modified Eagle’s Minimum Essential Medium (ATCC) passaged by detachment using 0.25% trypsin-EDTA (Gibco).

    Article Title: The CNS microenvironment promotes leukemia cell survival by disrupting tumor suppression and cell cycle regulation in pediatric T-cell acute lymphoblastic leukemia.
    Article Snippet: T-ALL cell lines CCL-119 and SUP-T1 (ATCC) were cultured in suspension in RPMI with 10% FBS (Sigma-Aldrich). .. T-ALL cell line MOLT16 (Leibniz Institute DSMZ) was cultured in suspension in IMDM (Gibco) with 10% FBS. .. Immortalized Human Meningeal Cells (IMHMCs) (Innoprot) were cultured in complete Meningeal Cell Medium (MenCM) (Innoprot) and passaged by detachment using Primary Cells Detach Kit (Innoprot).

    Article Title: A Distinct Alternative mRNA Splicing Profile Identifies the Oncogenic CD44 Transcript Variant 3 in KMT2A-Rearranged Pediatric T-cell Acute Lymphoblastic Leukemia Cells
    Article Snippet: T-ALL cell lines Jurkat and CCL-119 (ATCC) were cultured in suspension in RPMI with 10% FBS (Sigma-Aldrich). .. T-ALL cell line MOLT16 (Leibniz Institute DSMZ) was cultured in suspension in IMDM (Gibco) with 10% FBS. .. KMT2A-r cell line KARPAS-45 was cultured in suspension using RPMI supplemented with 2mM glutamine and 20% FBS (Sigma-Aldrich).



    Similar Products

    cell line molt16  (DSMZ)
    94
    DSMZ cell line molt16
    Cell Line Molt16, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+line+molt16/MOLT-16/bio_rxiv__2024__09__05__611385-34-1-4
    Average 94 stars, based on 1 article reviews
    cell line molt16 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    human cell lines molt16  (DSMZ)
    94
    DSMZ human cell lines molt16
    Human Cell Lines Molt16, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+line+molt16/MOLT-16/pm29158376-189-0-13
    Average 94 stars, based on 1 article reviews
    human cell lines molt16 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    human cell line molt16  (DSMZ)
    94
    DSMZ human cell line molt16
    A) Ten T-ALL cell lines were grown in a range of LEE011 concentrations and viability evaluated at day 6 by an ATP-based assay as the percentage of viable cells relative to a DMSO control. Shown are the mean ± standard deviation (SD) of 4 replicates. B) Western immunoblotting showing expression of ICN1, RB, Cyclin D3, CDK4 and CDK6 in a panel of T-ALL cell lines. C) Table showing calculated IC50 values for LEE011 treatment from the dose-response curves in panel A. Also annotated is the ICN1 and RB1 status for each cell line. D) Western immunoblotting showing a decrease in phosphorylation of RB with increasing concentrations of LEE011 in ICN1 positive (MOLT4) and negative <t>(MOLT16)</t> cell lines. E) Cell cycle analysis in MOLT4 and MOLT16 cells treated with increasing concentrations of LEE011. F) Ratio of Annexin V positive cells to control with increasing concentrations of LEE011 treatment of MOLT4 and MOLT16 cells. Shown are the mean ± standard error of mean (SEM) of 2 separate experiments. G) Correlation of ratio of Annexin V positive cells (relative to control) versus ratio of Cell Titer-Glo (CTG) Luminescence (relative to control) of cells treated with increasing concentrations of LEE011 at the indicated doses. Numbers indicate LEE011 concentration in μM units.
    Human Cell Line Molt16, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cell+line+molt16/MOLT-16/pmc05432118-70-8-16
    Average 94 stars, based on 1 article reviews
    human cell line molt16 - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    A) Ten T-ALL cell lines were grown in a range of LEE011 concentrations and viability evaluated at day 6 by an ATP-based assay as the percentage of viable cells relative to a DMSO control. Shown are the mean ± standard deviation (SD) of 4 replicates. B) Western immunoblotting showing expression of ICN1, RB, Cyclin D3, CDK4 and CDK6 in a panel of T-ALL cell lines. C) Table showing calculated IC50 values for LEE011 treatment from the dose-response curves in panel A. Also annotated is the ICN1 and RB1 status for each cell line. D) Western immunoblotting showing a decrease in phosphorylation of RB with increasing concentrations of LEE011 in ICN1 positive (MOLT4) and negative (MOLT16) cell lines. E) Cell cycle analysis in MOLT4 and MOLT16 cells treated with increasing concentrations of LEE011. F) Ratio of Annexin V positive cells to control with increasing concentrations of LEE011 treatment of MOLT4 and MOLT16 cells. Shown are the mean ± standard error of mean (SEM) of 2 separate experiments. G) Correlation of ratio of Annexin V positive cells (relative to control) versus ratio of Cell Titer-Glo (CTG) Luminescence (relative to control) of cells treated with increasing concentrations of LEE011 at the indicated doses. Numbers indicate LEE011 concentration in μM units.

    Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

    Article Title: Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia

    doi: 10.1158/1078-0432.CCR-15-2869

    Figure Lengend Snippet: A) Ten T-ALL cell lines were grown in a range of LEE011 concentrations and viability evaluated at day 6 by an ATP-based assay as the percentage of viable cells relative to a DMSO control. Shown are the mean ± standard deviation (SD) of 4 replicates. B) Western immunoblotting showing expression of ICN1, RB, Cyclin D3, CDK4 and CDK6 in a panel of T-ALL cell lines. C) Table showing calculated IC50 values for LEE011 treatment from the dose-response curves in panel A. Also annotated is the ICN1 and RB1 status for each cell line. D) Western immunoblotting showing a decrease in phosphorylation of RB with increasing concentrations of LEE011 in ICN1 positive (MOLT4) and negative (MOLT16) cell lines. E) Cell cycle analysis in MOLT4 and MOLT16 cells treated with increasing concentrations of LEE011. F) Ratio of Annexin V positive cells to control with increasing concentrations of LEE011 treatment of MOLT4 and MOLT16 cells. Shown are the mean ± standard error of mean (SEM) of 2 separate experiments. G) Correlation of ratio of Annexin V positive cells (relative to control) versus ratio of Cell Titer-Glo (CTG) Luminescence (relative to control) of cells treated with increasing concentrations of LEE011 at the indicated doses. Numbers indicate LEE011 concentration in μM units.

    Article Snippet: Cell culture, cell viability and apoptosis assays The human cell line MOLT16 was purchased from Leibniz-Institut DSMZ-German collection of microorganisms and cell cultures.

    Techniques: ATP Assay, Control, Standard Deviation, Western Blot, Expressing, Phospho-proteomics, Cell Cycle Assay, Concentration Assay

    Combination index analysis for the combinations of LEE011 with A) methotrexate, B) mercaptopurine, C) L-asparaginase and D) doxorubicin in MOLT4 and MOLT16 cells treated for 6 days in replicates of 4.

    Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

    Article Title: Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia

    doi: 10.1158/1078-0432.CCR-15-2869

    Figure Lengend Snippet: Combination index analysis for the combinations of LEE011 with A) methotrexate, B) mercaptopurine, C) L-asparaginase and D) doxorubicin in MOLT4 and MOLT16 cells treated for 6 days in replicates of 4.

    Article Snippet: Cell culture, cell viability and apoptosis assays The human cell line MOLT16 was purchased from Leibniz-Institut DSMZ-German collection of microorganisms and cell cultures.

    Techniques:

    A) A luciferized MOLT16 mouse model was treated with vehicle, dexamethasone (D) 15 mg/kg, LEE011 (L) 75 mg/kg, everolimus (E) 5mg/kg, or the combination of LEE011 with dexamethasone (L+D) or LEE011 with everolimus (L+E) after detectable disease was established. Spleen weight was analyzed in 3 mice per group after 5 days of treatment. Shown is the average spleen weight; error bars represent SD for 3 mice per group. B) Kaplan Meier curves showing overall survival of mice (n=10 per group) treated with vehicle, dexamethasone, LEE011 or the combination. * represents P-value <0.05 calculated using log-rank test. C) Kaplan Meier curves showing overall survival of mice (n=10 per group) treated with vehicle, everolimus, LEE011 or the combination. * shows P-value <0.05 calculated using log-rank test, *** shows P-value <0.001 calculated using log-rank test, **** shows P-value <0.0001 calculated using log-rank test. D) Mean fluorescence intensity (MFI) of p-4E-BP1 and E) pRB levels from peripheral blood cells measured by flow cytometry from mice treated for 5 days with drugs as indicated. Vehicle-treated mice are shown in black and drug-treated mice are shown in red. Each bar represents a single mouse. A luciferized MOLT4 mouse model was treated with vehicle, dexamethasone (D) 15 mg/kg, LEE011 (L) 75 mg/kg, or the combination of LEE011 with dexamethasone (L+D) after detectable disease was established. F) Spleen weight was analyzed from 3 mice per group after 5 days of treatment. Shown is the average spleen weight; error bars represent SD for 3 mice. * represents P-value <0.05 and ** represents P-value <0.005 calculated by paired t-test, n=3. G) Kaplan-Meier curves showing overall survival of mice (n=10 per group). P-value calculated using log-rank test. P-value <0.0001 between group treated with combination of LEE011 and dexamethasone and any individual treatment groups. H) Histology of mice treated with vehicle, LEE011, dexamethasone and combination of LEE011 and dexamethasone. Mice were treated for 5 days and tissue collected 3 hours after dosing. Shown are representative sections of bone marrow stained with p-RB S807/811. Images taken at 200× magnification.

    Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

    Article Title: Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia

    doi: 10.1158/1078-0432.CCR-15-2869

    Figure Lengend Snippet: A) A luciferized MOLT16 mouse model was treated with vehicle, dexamethasone (D) 15 mg/kg, LEE011 (L) 75 mg/kg, everolimus (E) 5mg/kg, or the combination of LEE011 with dexamethasone (L+D) or LEE011 with everolimus (L+E) after detectable disease was established. Spleen weight was analyzed in 3 mice per group after 5 days of treatment. Shown is the average spleen weight; error bars represent SD for 3 mice per group. B) Kaplan Meier curves showing overall survival of mice (n=10 per group) treated with vehicle, dexamethasone, LEE011 or the combination. * represents P-value <0.05 calculated using log-rank test. C) Kaplan Meier curves showing overall survival of mice (n=10 per group) treated with vehicle, everolimus, LEE011 or the combination. * shows P-value <0.05 calculated using log-rank test, *** shows P-value <0.001 calculated using log-rank test, **** shows P-value <0.0001 calculated using log-rank test. D) Mean fluorescence intensity (MFI) of p-4E-BP1 and E) pRB levels from peripheral blood cells measured by flow cytometry from mice treated for 5 days with drugs as indicated. Vehicle-treated mice are shown in black and drug-treated mice are shown in red. Each bar represents a single mouse. A luciferized MOLT4 mouse model was treated with vehicle, dexamethasone (D) 15 mg/kg, LEE011 (L) 75 mg/kg, or the combination of LEE011 with dexamethasone (L+D) after detectable disease was established. F) Spleen weight was analyzed from 3 mice per group after 5 days of treatment. Shown is the average spleen weight; error bars represent SD for 3 mice. * represents P-value <0.05 and ** represents P-value <0.005 calculated by paired t-test, n=3. G) Kaplan-Meier curves showing overall survival of mice (n=10 per group). P-value calculated using log-rank test. P-value <0.0001 between group treated with combination of LEE011 and dexamethasone and any individual treatment groups. H) Histology of mice treated with vehicle, LEE011, dexamethasone and combination of LEE011 and dexamethasone. Mice were treated for 5 days and tissue collected 3 hours after dosing. Shown are representative sections of bone marrow stained with p-RB S807/811. Images taken at 200× magnification.

    Article Snippet: Cell culture, cell viability and apoptosis assays The human cell line MOLT16 was purchased from Leibniz-Institut DSMZ-German collection of microorganisms and cell cultures.

    Techniques: Fluorescence, Flow Cytometry, Staining